Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus

Nephrology Dialysis Transplantation

Volumn 30, Issue 3, 2015, Pages 467-474

  Caro, Jara ^a   Gutiérrez Solís, Elena ^a   Rojas Rivera, Jorge ^b   Agraz, Irene ^c   Ramos, Natalia ^c   Rabasco, Cristina ^d   Espinosa, Mario ^d   Valera, Alfonso ^e   Martín, Mónica ^e   Frutos, Miguel Ángel ^f   Perea, Lara ^f   Juárez, Gema Fernández ^g   Ocaña, Javier ^g   Arroyo, David ^h   Goicoechea, Marian ^h   Fernández, Laura ⁱ   Oliet, Aniana ^j   Hernández, Yolanda ^k   Romera, Ana ^l   Segarra, Alfons ^c   Praga, Manuel ^a,m   more..

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^f HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^g HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^h HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

ⁱ HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^j HOSPITAL SEVERO OCHOA   (Spain)

^k HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^l HOSPITAL GENERAL UNIVERSITARIO DE CIUDAD REAL   (Spain)

^m UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

more..

Author keywords

membranous nephropathy; nephrotic syndrome; tacrolimus monotherapy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CHLORAMBUCIL; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOCAL EPILEPSY; HEADACHE; HEART INFARCTION; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IDIOPATHIC MEMBRANOUS GLOMERULONEPHRITIS; INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MIDDLE AGED; MONOTHERAPY; NEPHROTIC SYNDROME; NEPHROTOXICITY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT DURATION; TREMOR; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; CASE CONTROL STUDY; COMPARATIVE STUDY; GLOMERULONEPHRITIS, MEMBRANOUS; INCIDENCE; PROGNOSIS; RECURRENT DISEASE;

CASE-CONTROL STUDIES; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROTEINURIA; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TACROLIMUS;

EID: 84924386892     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu306     Document Type: Article

References (26)

1. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group: KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int 1992; 2(Suppl 2): 186-197
2. Ponticelli C, Zucchelli P, Passerini P et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995; 48: 1600-1604
3. Ponticelli C, Zucchelli P, Passerini P et al. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. N Engl J Med 1992; 327: 599-603
4. Ponticelli C, Altieri P, Scolari F et al. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol 1998; 9: 444-450
5. Hofstra JM, Wetzels JF. Alkylating agents in membranous nephropathy: efficacy proven beyond doubt. Nephrol Dial Transplant 2010; 25: 1760-1766
6. Cattran DC, Appel GB, Hebert LA et al. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int 2001; 59: 1484-1490
7. Cattran DC, Greenwood C, Ritchie S et al. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney Int 1995; 47: 1130-1135
8. DeSanto NG, Capodicasa G, Giordano C. Treatment of idiopathic membranous nephropathy unresponsive to methylprednisolone and chlorambucil with cyclosporin. Am J Nephrol 1987; 7: 74-76
9. Rostoker G, Belghiti D, Ben Maadi A et al. Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy. Nephron 1993; 63: 335-341
10. Meyrier A, Noel LH, Auriche P et al. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Societe de Nephrologie. Kidney Int 1994; 45: 1446-1456
11. Cattran DC, Alexopoulos E, Heering P et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations. Kidney Int 2007; 72: 1429-1447
12. Praga M, Barrio V, Juarez GF et al. Tacrolimus monotherapy in membranous nephropathy: a randomized controlled trial. Kidney Int 2007; 71: 924-930
13. Fervenza FC, Sethi S, Specks U. Idiopathic membranous nephropathy: Diagnosis and treatment. Clin J Am Soc Nephrol 2008; 3: 905-919
14. Hofstra JM, Fervenza FC, Wetzels JF. Treatment of idiopathic membranous nephropathy. Nat Rev Nephrol 2013; 9: 443-458
15. Torres A, Domínguez-Gil B, Carreño A et al. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy and deteriorating renal function. Kidney Int 2002; 61: 219-227
16. du Buf-Vereijken PWG, Branten AJW, Wetzels JFM. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy. Am J Kidney Dis 2005; 46: 1012-1029
17. Glassock RJ. Diagnosis and natural course of membranous nephropathy. Semin Nephrol 2003; 23: 324-332
18. Ballarin J, Poveda R, Ara J et al. Treatment of idiopathic membranous nephropathy with the combination of steroids, tacrolimus and mycophenolate mofetil: results of a pilot study. Nephrol Dial Transplant 2007; 22: 3196-3201
19. Segarra A, Praga M, Ramos N et al. Successful treatment of membranous glomerulonephritis with rituximab in calcineurin inhibitor-dependent patients. Clin J Am Soc Nephrol 2009; 4: 1083-1088
20. Ruggenenti P, Cravedi P, Chianca A et al. Rituximab in idiopathic membranous mephropathy. J Am Soc Nephrol 2012; 23: 1416-1425
21. Ruggenenti P, Chiurchiu C, Brusegan V et al. Rituximab in idiopathic membranous nephropathy: a one year prospective study. J Am Soc Nephrol 2003; 14: 1851-1857
22. Fervenza FC, Abraham RS, Erickson SB et al. Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol 2010; 5: 2188-2198
23. Howman A, Chapman TL, Langdon MM et al. Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial. Lancet 2013; 381: 744-751
24. Goumenos DS, Katapodis KP, Passadakis P et al. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs. Am J Nephrol 2007; 27: 226-231
25. Chen M, Li H, Li XY et al. Chinese Nephropathy Membranous Study Group. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial. Am J Med Sci 2010; 339: 233-238
26. Segarra A, Jatem E, Carnicer C et al. Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus. Nefrología 2014; 34: 491-497